Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Suneeta Sunny

Over 20% Of COVID Patients Treated With Paxlovid Suffer Virologic Rebound: Study

Paxlovid is an antiviral pill targeted to help COVID-19 patients who are at high risk of developing severe disease. (Credit: pixabay/ DarkoStojanovic)

An antiviral drug, Paxlovid, used for treating severe symptoms of COVID-19 is linked with virologic rebound, a new study has found.

COVID rebound is a condition wherein after initial recovery and negative test, a patient either tests positive again, sheds live, potentially contagious virus or experiences the symptoms.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.